Clinical Trials · NCT00493961

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

CompletedPhase 1Gonadorelin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Massachusetts General Hospital
Enrollment
27
Start date
Jan 1999
Locations
1 site, United States
Primary endpoint
testosterone
View Gonadorelin compound reference